WallStreetZenWallStreetZen

NASDAQ: CHRS
Coherus Biosciences Inc Stock Forecast, Predictions & Price Target

Analyst price target for CHRS

Based on 4 analysts offering 12 month price targets for Coherus Biosciences Inc.
Min Forecast
$7.00+167.18%
Avg Forecast
$9.25+253.05%
Max Forecast
$13.00+396.18%

Should I buy or sell CHRS stock?

Based on 4 analysts offering ratings for Coherus Biosciences Inc.
Strong Buy
Strong Buy
2 analysts 50%
Buy
2 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CHRS stock forecasts and price targets.

CHRS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-01-23
lockedlocked$00.00+00.00%2024-01-23
lockedlocked$00.00+00.00%2023-12-27
lockedlocked$00.00+00.00%2023-10-23

1 of 1

Forecast return on equity

Is CHRS forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.69%

Forecast return on assets

Is CHRS forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

CHRS revenue forecast

What is CHRS's revenue in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
$348.7M+65.19%
Avg 2 year Forecast
$406.1M+92.41%
Avg 3 year Forecast
$627.7M+197.38%
CHRS's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CHRS revenue growth forecast

How is CHRS forecast to perform vs Biotechnology companies and vs the US market?
Company
40.13%
Industry
53.39%
Market
11.2%
CHRS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CHRS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CHRS vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CHRS$2.62$9.25+253.05%Strong Buy
ANNX$5.49$11.00+100.36%Strong Buy
CDXS$4.15$9.50+128.92%Strong Buy
AGEN$0.78N/AN/A
ENTA$14.05$19.60+39.50%Hold

Coherus Biosciences Stock Forecast FAQ

Is Coherus Biosciences Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: CHRS) stock is to Strong Buy CHRS stock.

Out of 4 analysts, 2 (50%) are recommending CHRS as a Strong Buy, 2 (50%) are recommending CHRS as a Buy, 0 (0%) are recommending CHRS as a Hold, 0 (0%) are recommending CHRS as a Sell, and 0 (0%) are recommending CHRS as a Strong Sell.

If you're new to stock investing, here's how to buy Coherus Biosciences stock.

What is CHRS's revenue growth forecast for 2024-2026?

(NASDAQ: CHRS) Coherus Biosciences's forecast annual revenue growth rate of 40.13% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 53.39%, and while it is forecast to beat the US market's average forecast revenue growth rate of 11.2%.

Coherus Biosciences's revenue in 2024 is $211,072,000.On average, 4 Wall Street analysts forecast CHRS's revenue for 2024 to be $38,828,447,965, with the lowest CHRS revenue forecast at $28,397,858,760, and the highest CHRS revenue forecast at $45,742,825,434. On average, 4 Wall Street analysts forecast CHRS's revenue for 2025 to be $45,227,209,410, with the lowest CHRS revenue forecast at $27,841,038,000, and the highest CHRS revenue forecast at $54,538,366,159.

In 2026, CHRS is forecast to generate $69,902,721,390 in revenue, with the lowest revenue forecast at $69,379,866,696 and the highest revenue forecast at $70,425,576,083.

What is CHRS's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: CHRS) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is CHRS's Price Target?

According to 4 Wall Street analysts that have issued a 1 year CHRS price target, the average CHRS price target is $9.25, with the highest CHRS stock price forecast at $13.00 and the lowest CHRS stock price forecast at $7.00.

On average, Wall Street analysts predict that Coherus Biosciences's share price could reach $9.25 by Jan 23, 2025. The average Coherus Biosciences stock price prediction forecasts a potential upside of 253.05% from the current CHRS share price of $2.62.

What is CHRS's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: CHRS) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.